Home

Press Releases

About

Editorial

Advertise

Cookie Policy

Privacy

Contact

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

SUBSCRIBE

Market Reports

FDA

Executives

Funding

Non Profits

Hospitals

Acquisitions

Health

Biotechnology News Magazine

Dr Cory Calendine Appointed to Osso VR Advisory Board

Orthopedic surgeon at Bone and Joint Institute of Tennessee joins Osso VR to advance global development and adoption of VR surgical training technology

Share the News

Dr. Cory Calendine, M.D., an orthopedic surgeon at the Bone and Joint Institute of Tennessee, has officially joined the Osso VR Clinical Advisory Board.

Dr. Cory Calendine’s extensive experience in arthroplasty and advanced surgical technologies provides Osso VR and its executive team a valuable resource to accelerate the development of the company’s leading surgical training platform.

Dr. Calendine is a board-certified orthopaedic surgeon specializing in both traditional and robotic total joint arthroplasty. He received his medical degree from the University of Tennessee College of Medicine, completed a residency in orthopaedic surgery at Vanderbilt University Medical Center, and did his fellowship training in adult reconstruction of the hip and knee at the world-renowned Anderson Orthopaedic Research Institute in Alexandria, Virginia.
“I am humbled and honored to be joining the Osso VR advisory board. Osso VR is on the cutting edge of surgical training technology and is producing world-changing technology at a truly global scale. In addition, the team has such a warm, fun-loving culture.  At the end of the day, I was drawn not just to their technology and culture, but also to their mission of democratizing global access to the latest surgical techniques, something that I am extremely passionate about and proud to be a part of.” said Dr. Cory Calendine, M.D.
Osso VR’s surgical training technology provides on-demand, immersive experiences that are effective, repeatable, and measurable to help surgeons reach proficiency with new procedures and devices. The platform has become integral to surgical training programs worldwide and is currently used by thousands of surgeons each month in 20+ leading teaching hospitals and over 15 top medical device companies in over 20 countries.
“I’ve admired the work of Dr. Calendine for years, and I am humbled that he’s joined our advisory board team to continue driving our technology and VR surgical adoption throughout the globe. Innovation in healthcare is not just about developing new technology but also how you communicate about that technology. Dr. Calendine is reshaping the way we are thinking about communication partially through his innovative use of social media to educate healthcare professionals and the public on the value of emerging medical technologies.” said Justin Barad, MD, CEO and co-founder of Osso VR. “Dr. Calendine not only brings his unique expertise to Osso VR, but he also has a passion for democratizing healthcare which is a core part of our mission.”
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Must Read

PathGroup Acquires Pathology Consultants, Continuing Expansion Across the Southeastern United States

“PathGroup and Pathology Consultants are complementary partners with shared values. Together we will provide the highest-quality pathology services to our clients and patients,” said David P. Schammel, M.D., Medical Director of Pathology Consultants. “We look forward to working with PathGroup to continue to exceed the expectations of our health systems and physician clients.”

Arsenal Acquires Automation Solutions Provider Eckhart from LFM Capital

Daniel Burseth, Vice President of Eckhart, remarked, "The partnership with Arsenal comes at an opportune time as our customers invest at a record rate in automation for their operations.

ACON Exits iiMED Medical Solutions and Completes Full Exit of its IIMAK Investment

"ACON's experience and resources were instrumental in fueling iiMED's accelerated organic growth over the past three years. Our partnership with ACON was highly collaborative and critical to our success. We are excited to partner with TEAM to further build upon our exciting growth trajectory," said Bill Flaherty, CEO of iiMED.
Subscribe to Biotechnology News Magazinespot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy